2023
DOI: 10.1016/j.nut.2023.112000
|View full text |Cite
|
Sign up to set email alerts
|

Thiamine pharmaconutrition in sepsis: Monotherapy, combined therapy, or neither? Current evidence on safety and efficacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Currently, there is a lack of substantial clinical evidence to endorse the regular administration of high-dose thiamine with the intention of enhancing outcomes in cases of septic shock. Hence, it is recommended that the administration of high-dose intravenous thiamine be limited to patients who have been confirmed to have a thiamine deficiency [11 ▪▪ ].…”
Section: Thiamine Deficiency During Critical Illnessmentioning
confidence: 99%
“…Currently, there is a lack of substantial clinical evidence to endorse the regular administration of high-dose thiamine with the intention of enhancing outcomes in cases of septic shock. Hence, it is recommended that the administration of high-dose intravenous thiamine be limited to patients who have been confirmed to have a thiamine deficiency [11 ▪▪ ].…”
Section: Thiamine Deficiency During Critical Illnessmentioning
confidence: 99%